<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51">
 <label>51</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brown</surname>
    <given-names>CE</given-names>
   </name>
   <name>
    <surname>Alizadeh</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Starr</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Weng</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Wagner</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Naranjo</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Regression of glioblastoma after chimeric antigen receptor T-cell therapy</article-title>. 
  <source>N Engl J Med</source> (
  <year>2016</year>) 
  <volume>375</volume>(
  <issue>26</issue>):
  <page-range>2561–9</page-range>.  
  <pub-id pub-id-type="doi">10.1056/NEJMoa1610497</pub-id>
 </mixed-citation>
</ref>
